Tolera Therapeutics
Latest round
- Series B
Last raised
- Oct 2012
Total raised
- $18M
Investors
- 3
About Tolera Therapeutics
Tolera Therapeutics Inc.Tolera Therapeutics Inc. was founded in 2007 and is based in Kalamazoo, US. The company is dedicated to the development of therapies that aim to promote immune tolerance in autoimmune disease treatment., and Triathlon Medical Partners.com offers a premium domain name that serves as a versatile platform for brands looking to establish or enhance their online presence. The domain is positioned as a valuable asset for businesses aiming to adapt and thrive in a changing marketplace, particularly in the realms of business and strategy. The company focuses on facilitating the sale of its domain through various purchasing options, including outright purchase and structured payment plans.com is targeted towards a diverse client base, including entrepreneurs, startups, and established companies across global markets such as North America, Europe, and Asia.com is primarily based on the sale of domain names, specifically through direct transactions with clients. Customers can choose from a range of payment options, which include a one-time purchase price or a payment plan that allows for an initial deposit followed by monthly installments.66 and subsequent monthly payments of USD 184 over 23 months.In September 2014, Tolera Therapeutics Inc.25 million in VENTURE DEBT to enhance its development programs. Specific upcoming products have not been detailed, but there is an intent to explore further opportunities within the biopharmaceutical sector. Additionally, Tolera is considering expansion into new markets, particularly in Europe and Asia, to broaden its reach and impact in the autoimmune disease treatment landscape.
Who invested in Tolera Therapeutics
3 investors across 3 rounds
See all investors in Tolera Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tolera Therapeutics
Who invested in Tolera Therapeutics?
Tolera Therapeutics has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tolera Therapeutics raised?
Tolera Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Tolera Therapeutics last raise money?
Tolera Therapeutics's most recent round on record is a Series B, in Oct 2012.
What does Tolera Therapeutics do?
Tolera Therapeutics is a biotechnology company.
Where is Tolera Therapeutics headquartered?
Tolera Therapeutics is headquartered in Kalamazoo, US.
Which VCs invest in companies like Tolera Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tolera Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Tolera Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.